The Fight Against Counterfeiting in the Pharmaceutical Sector: An Overview of Key Regulatory, Preventive and Intellectual Property Enforcement Measures in France

Although not as high as for other industries, pharmaceuticals are vulnerable to counterfeiting and are amongst the topmost counterfeited products. Indeed, according to the OECD/EUIPO (2019) study, the value of global trade in counterfeit pharmaceuticals was up to USD 4.4 billion in 2016.

Read the article of Karine Disdier-Mikus published in EPLR – European Pharmaceutical Law Review 4/2021, 10/2021.

Partager :